Abstract
Anticancer drug targeting to liver asialoglycoprotein receptors (ASGPR) is viewed as a good approach for hepatocellular carcinoma (HCC) treatment. Lac......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
